3422
D. Mutisya et al. / Bioorg. Med. Chem. Lett. 21 (2011) 3420–3422
that pair may be slightly distorted or dynamic allowing some
water access. The relative flexibility of the central AU pair is consis-
tent with reduced intensity of the CD signal for RNA4 (Fig. 2B).
In summary, we found that the triazole 30-O–CH2–C@CH–N-50
linkage strongly destabilized RNA double helix (D m –7 to –14 °C
t
per modification) and is not a good mimic of the phosphate linkage
in RNA. Our results on the triazole linkage that has four bonds (30-
O–CH2–C@CH–N-50) instead of the two bonds long phosphate (30-
O–P(O)2–O-50) linkage are in contrast to results reported by Isobe
et al.8 who found that the two bonds long triazole (30-N–CH@CH-
50) linkage strongly stabilized DNA. The most likely explanation
for these differences is that the significantly longer linkage adopts
a conformation that is less than optimal for RNA double helix and
causes the flexibility of the UA base pairs as suggested by the NMR
and CD spectra of RNA4. Depending on the sequence the duplex
may become disordered, as suggested by the lack of CD signal for
RNA1 and RNA3. The striking observation that modified duplexes
with similar melting curves gave different CD spectra underlines
the need for careful and comprehensive biophysical studies before
conclusions can be made about the properties of a nucleic acid
modification.
Acknowledgments
We thank National Institutes of Health (R01 GM071461) for
financial support of this research and Dr. Pradeep S. Pallan
(Vanderbilt University) for help with MALDI-TOF MS.
Figure 3. NMR spectra and 2D water–NOESY spectrum of RNA4 duplex (0.1 mM).
Upper left: 1D spectra of the imino proton region of the duplex (upper right with
numbering) showing that U4 imino is only observed at low temperature. Bottom:
2D water–NOESY acquired at 1 °C with mixing time of 150 ms. Red circles indicate
A5 H2 NOEs to U4 imino, C6 H10, and cross-strand A5 H10. Cytosine intramolecular
amino–amino cross-peaks typical in Watson–Crick GC pairs are labeled, including
C8 in the terminal base pair for which no G imino is observed. Strong cross-peaks
from G3 and G7 iminos to C6 and C2 aminos, respectively, indicate GC
Watson–Crick pairs.
Supplementary data
Supplementary data (experimental procedures, copies of HPLC
traces, UV melting curves, CD and NMR spectra) associated with
this article can be found, in the online version, at doi:10.1016/
References and notes
triazole modification made RNA duplexes more flexible and that
RNA1 and RNA3 might be significantly disordered even at temper-
atures well below the tm obtained by UV melting (20 and 0 °C,
respectively).
To gain insight into base pair formation in the triazole modified
RNA we studied RNA4 using NMR techniques.15 Spectra in 95%
H2O/5% D2O exhibit three clear imino proton signals (Fig. 3, top),
one of which is clear only at low temperature where exchange of
the imino proton with water is sufficiently slowed.
Strong NOEs to cytosine amino protons allow assignment of the
two temperature-stable imino protons to G3 and G7 in GC base
pairs. An NOE to the H2 proton of the lone adenine, despite the
high rate of exchange with water, identifies the third imino peak
as belonging to uracil in an AU base pair. Further evidence of this
AU pair is contained in typical NOEs from adenine H2 to the
cross-strand adenine H10 and to the intrastrand H10 of C6. Finally,
the chemical shift of the adenine H2 proton (7.14 ppm) is nearly
identical to that observed for the amide-modified and the unmod-
ified RNA in our previous study (7.08 ppm).3a While no imino pro-
ton signal was observed for the terminal guanosine (G1), formation
of the closing GC base pair was suggested by the chemical shifts of
C8 amino protons. One of these was shifted greater than 1 ppm
downfield relative to the other, suggesting involvement in a
hydrogen bond of one proton but not the other. This pattern,
similar to that observed for C2 and C6 amino protons, is typical
of Watson–Crick GC pairs. Thus, the NMR evidence indicates
formation of a duplex that includes the central AU pair, although
1. Watts, J. K.; Corey, D. R. Bioorg. Med. Chem. Lett. 2010, 20, 3203.
2. (a) Watts, J. K.; Deleavey, G. F.; Damha, M. J. Drug Discovery Today 2008, 13, 842;
(b) Corey, D. R. J. Clin. Invest. 2007, 117, 3615; (c) Rozners, E. Curr. Org. Chem.
2006, 10, 675; (d) Manoharan, M. Curr. Opin. Chem. Biol. 2004, 8, 570.
3. (a) Selvam, C.; Thomas, S.; Abbott, J.; Kennedy, S. D.; Rozners, E. Angew. Chem.,
Int. Ed. 2011, 50, 2068; (b) Rozners, E.; Katkevica, D.; Bizdena, E.; Strömberg, R.
J. Am. Chem. Soc. 2003, 125, 12125.
4. (a) Kolarovic, A.; Schweizer, E.; Greene, E.; Gironda, M.; Pallan, P. S.; Egli, M.;
Rozners, E. J. Am. Chem. Soc. 2009, 131, 14932; (b) Rozners, E.; Katkevica, D.;
Strömberg, R. Chem. Biol. Chem. 2007, 8, 537; (c) Rozners, E.; Strömberg, R. J.
Org. Chem. 1997, 62, 1846.
5. (a) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int.
Ed. 2002, 41, 2596; (b) Tornoe, C. W.; Christensen, C.; Meldal, M. J. Org. Chem.
2002, 67, 3057.
6. For a recent review, see: El-Sagheer, A. H.; Brown, T. Chem. Soc. Rev. 2010, 39,
1388.
7. (a) Von Matt, P.; Lochmann, T.; Altmann, K.-H. Bioorg. Med. Chem. Lett. 1997, 7,
1549; (b) Von Matt, P.; Altmann, K.-H. Bioorg. Med. Chem. Lett. 1997, 7, 1553.
8. (a) Isobe, H.; Fujino, T.; Yamazaki, N.; Guillot-Nieckowski, M.; Nakamura, E.
Org. Lett. 2008, 10, 3729; (b) Fujino, T.; Yamazaki, N.; Isobe, H. Tetrahedron Lett.
2009, 50, 4101.
9. El-Sagheer, A. H.; Brown, T. J. Am. Chem. Soc. 2009, 131, 3958.
10. Nuzzi, A.; Massi, A.; Dondoni, A. QSAR Comb. Sci. 2007, 1191.
11. (a) Lucas, R.; Zerrouki, R.; Granet, R.; Krausz, P.; Champavier, Y. Tetrahedron
2008, 64, 5467; (b) Lucas, R.; Neto, V.; Hadj Bouazza, A.; Zerrouki, R.; Granet, R.;
Krausz, P.; Champavier, Y. Tetrahedron Lett. 2008, 49, 1004; (c) Lucas, R.;
Elchinger, P. H.; Faugeras, P. A.; Zerrouki, R. Nucleosides Nucleotides Nucleic
Acids 2010, 29, 168.
12. El-Sagheer, A. H.; Brown, T. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 15329.
13. Yamamoto, I.; Sekine, M.; Hata, T. J. Chem. Soc., Perkin Trans. 1 1980, 306.
14. Srivastava, S.C.; Raza, S.K. U.S. Patent US 5 744 595, 1998
15. Hammond, N. B.; Tolbert, B. S.; Kierzek, R.; Turner, D. H.; Kennedy, S. D.
Biochemistry 2010, 49, 5817.